Serum SFRP4 levels in patients with stable coronary artery disease (CAD) are also positively correlated with body mass index (BMI), waist circumference and triglycerides, all contributors to metabolic syndrome [15]. This evidence concerns the gene SFRP4 and coronary artery disorder.